Tachypnoea adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 13,332 adverse event reports that record the MedDRA preferred term Tachypnoea. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 891 reports in the 12 months to June 2026 and 919 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 664 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 891 (0.1%) record this term. Reports for male patients were 47% of the reports that record this term and 34.6% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 90 drug pages with 50 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Tachypnoea name as a suspect product, in order of name
Drug	Class	Reports with this term
Acetaminophen		192
Acetylsalicylic Acid		62
Albuterol	beta2-Adrenergic agonist	55
Albuterol sulfate	beta2-Adrenergic agonist	67
Alprazolam	Benzodiazepine	76
Amlodipine	Calcium channel blocker	165
Amoxicillin	Penicillin-class antibacterial	62
Apixaban	Factor Xa inhibitor	69
Aspirin	Nonsteroidal anti-inflammatory drug	195
Azithromycin	Macrolide antimicrobial	56
Azithromycin Anhydrous		54
Baclofen	gamma-Aminobutyric acid-ergic agonist	57
Bamlanivimab		50
Bisoprolol	beta-Adrenergic blocker	81
Budesonide	Corticosteroid	92
Carboplatin	Platinum-based drug	186
Ceftriaxone	Cephalosporin antibacterial	99
Cefuroxime	Cephalosporin antibacterial	51
Ciprofloxacin	Fluoroquinolone antibacterial	104
Cisplatin	Platinum-based drug	73
Clozapine	Atypical antipsychotic	105
Cyclophosphamide	Alkylating drug	262
Cyclosporine	Calcineurin inhibitor immunosuppressant	55
Cytarabine	Nucleoside metabolic inhibitor	217
Darzalex	CD38-directed cytolytic antibody	102
Daunorubicin		65
Dexamethasone	Corticosteroid	275
Diazepam	Benzodiazepine	89
Digoxin	Cardiac glycoside	57
Docetaxel	Microtubule inhibitor	75
Doxorubicin	Anthracycline topoisomerase inhibitor	97
Doxorubicin hydrochloride	Anthracycline topoisomerase inhibitor	79
Entresto	Angiotensin 2 receptor blocker	70
Etoposide	Topoisomerase inhibitor	129
Fentanyl	Opioid agonist	151
Fluconazole	Azole antifungal	53
Fluorouracil	Nucleoside metabolic inhibitor	94
Fluoxetine	Serotonin reuptake inhibitor	62
Furosemide	Loop diuretic	171
Haloperidol	Typical antipsychotic	75
Herceptin	HER2/neu receptor antagonist	53
Human immunoglobulin g	Human immunoglobulin G	71
Humira		64
Ibuprofen	Nonsteroidal anti-inflammatory drug	174
Ipratropium bromide	Anticholinergic	73
Jardiance	Sodium-Glucose cotransporter 2 inhibitor	59
Lamotrigine	Anti-epileptic agent	90
Levofloxacin	Fluoroquinolone antibacterial	51
Lorazepam	Benzodiazepine	105
Mabthera		69
Meropenem	Penem antibacterial	69
Metformin	Biguanide	319
Metformin hcl	Biguanide	92
Metformin hydrochloride	Biguanide	107
Methotrexate	Folate analog metabolic inhibitor	265
Methylprednisolone	Corticosteroid	134
Metoprolol	beta-Adrenergic blocker	66
Midazolam	Benzodiazepine	55
Morphine	Opioid agonist	54
Mycophenolate mofetil	Antimetabolite immunosuppressant	105
Olanzapine	Atypical antipsychotic	136
Omeprazole	Proton pump inhibitor	57
Omnipaque	Radiographic contrast agent	54
Oncaspar	Asparagine-specific enzyme	71
Ondansetron	Serotonin-3 receptor antagonist	73
Oxaliplatin	Platinum-based drug	167
Paclitaxel	Microtubule inhibitor	140
Paracetamol		92
Paxil	Serotonin reuptake inhibitor	63
Piperacillin and tazobactam	Penicillin-class antibacterial	56
Prednisolone	Corticosteroid	167
Prednisone	Corticosteroid	201
Privigen	Human immunoglobulin G	114
Propofol	General anesthetic	116
Quetiapine	Atypical antipsychotic	132
Ramipril	Angiotensin converting enzyme inhibitor	80
Remicade	Tumor necrosis factor blocker	87
Risperidone	Atypical antipsychotic	134
Rituximab	CD20-directed cytolytic antibody	143
Sertraline	Serotonin reuptake inhibitor	99
Sevoflurane	General anesthetic	50
Sodium chloride	Osmotic laxative	71
Synagis	Respiratory syncytial virus Anti-F protein monoclonal antibody	57
Tacrolimus	Calcineurin inhibitor immunosuppressant	119
Tramadol		67
Ultravist	Radiographic contrast agent	79
Valproic acid	Anti-epileptic agent	54
Vancomycin	Glycopeptide antibacterial	62
Vincristine		73
Vincristine sulfate	Vinca alkaloid	133

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 42 pharmacologic classes with 100 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Tachypnoea name, in order of name
Class	Reports with this term
Alkylating drug	380
Angiotensin 2 receptor blocker	173
Angiotensin converting enzyme inhibitor	154
Anthracycline topoisomerase inhibitor	208
Anti-epileptic agent	266
Anticholinergic	113
Antimetabolite immunosuppressant	138
Atypical antipsychotic	709
Benzodiazepine	441
beta-Adrenergic blocker	233
beta2-Adrenergic agonist	129
Biguanide	526
Calcineurin inhibitor immunosuppressant	193
Calcium channel blocker	174
CD20-directed cytolytic antibody	206
CD38-directed cytolytic antibody	152
Cephalosporin antibacterial	198
Corticosteroid	1,027
Factor Xa inhibitor	176
Fluoroquinolone antibacterial	168
Folate analog metabolic inhibitor	298
General anesthetic	178
HER2/neu receptor antagonist	125
Human immunoglobulin G	231
Kinase inhibitor	182
Loop diuretic	234
Microtubule inhibitor	215
Nonsteroidal anti-inflammatory drug	533
Nucleoside metabolic inhibitor	471
Opioid agonist	405
Osmotic laxative	134
P2Y12 platelet inhibitor	148
Penicillin-class antibacterial	154
Platinum-based drug	426
Proton pump inhibitor	149
Radiographic contrast agent	160
Serotonin and norepinephrine reuptake inhibitor	131
Serotonin reuptake inhibitor	421
Sodium-Glucose cotransporter 2 inhibitor	115
Topoisomerase inhibitor	163
Tumor necrosis factor blocker	159
Vinca alkaloid	133

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Tachypnoea, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Tachypnoea
Age	Reports	Share
Under 2	544	4.1%
2 to 11	629	4.7%
12 to 17	544	4.1%
18 to 44	2,411	18.1%
45 to 64	3,094	23.2%
65 to 74	2,020	15.2%
75 and over	1,896	14.2%
Age not given	2,194	16.5%

Sex of the patient in the reports that record Tachypnoea
Sex	Reports	Share
Female	6,063	45.5%
Male	6,261	47%
Unknown or not given	1,008	7.6%

Age and sex are as the report gives them. 32.2% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Tachypnoea: adverse event reports that record this term. https://reportedreactions.com/reaction/tachypnoea/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Tachypnoea mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page